Clinical information: triple negative ca breast R side; post-op septicemia on dose dense chemo. So chemo stopped, for adj RT. For FU PET/CT 4-6 months afterward to monitor disease.
Pet Scan report: F18-FDG was injected intravenously. PET imaging from head to upper thigh was taken after 60 minutes. Plain CT for attenuation correction and localization.
PET/CT findings: Blood glucose level 5 mmol/l at the time of FDG injection.
No gross hypermetabolic brain mass. The ventricles are not dilated. No midline shift. NP, tonsils, para-nasal nisuses and larynx are unremarkable. No enlarged hypermetabolic cervical lymphadenopathy seen.
Satus post right modified radical mastectomy with mild post-operative FDG activity over right anterior chest wall and axilla. No gross FDG-avid left breast mass seen. Small left axillary nodes with mild FDG activity (6mm, sUVmax1.7), likely reactive in nature.
Mildly hypermetabolic streaky opacity at right lung apex (lm94, 20mm, SUV max 2.1). Mildly hypermetabolic ground glass opacities at anterior right lung are seen, could be due to post-RT changes. mild bronchiectasis over medical RML noted. No enlarged hypermetabolic mediastinal lymphadenopathy. No pleura or pericardial effusion. No hypermetabolic mass over adrenals, liver, spleen, pancreas and kidneys. Gallstone noted. No enlarged hypermetabolic lymphadenopathy seen in abdomen and pelvis. The bowel uptake is unremarkable. No abnormal FDG focus over uterus. No ascites.
No hypermetabolic bone secondary is seen within the scanning range. (lymph nodes are measured in short axis)
Impression: 1. Status post right modified radical mastectomy. 2. Streaky opacity at right lung apex (lm94, 20mm, SUVmax2.1) with non-specific mild FDG activity. 3. No other gross FDG-aid metastasis is detected.
潘智文醫生(女)